Tag Archives: Douglas Tsao

H.C. Wainwright Sticks to Their Buy Rating for Amryt Pharma (AMYT)

H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Amryt Pharma (AMYT – Research Report) today and set a price target of $29.00. The company’s shares closed last Friday at $10.10, close to its 52-week low of $9.55. According

Analysts Offer Insights on Healthcare Companies: Minerva Neurosciences (NASDAQ: NERV), Angion Biomedica (NASDAQ: ANGN) and DBV Technologies SA – American (NASDAQ: DBVT)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Minerva Neurosciences (NERV – Research Report), Angion Biomedica (ANGN – Research Report) and DBV Technologies SA – American (DBVT – Research Report)

Analysts Offer Insights on Healthcare Companies: Daré Bioscience (NASDAQ: DARE) and Ascendis Pharma (NASDAQ: ASND)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Daré Bioscience (DARE – Research Report) and Ascendis Pharma (ASND – Research Report) with bullish sentiments. Daré Bioscience (DARE) H.C. Wainwright analyst

Analysts Conflicted on These Healthcare Names: SAGE Therapeutics (NASDAQ: SAGE), Axsome Therapeutics (NASDAQ: AXSM) and Morphosys Ag (NASDAQ: MOR)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on SAGE Therapeutics (SAGE – Research Report), Axsome Therapeutics (AXSM – Research Report) and Morphosys Ag (MOR – Research Report). SAGE Therapeutics (SAGE) H.C. Wainwright analyst

H.C. Wainwright Thinks Rezolute’s Stock is Going to Recover

In a report released today, Douglas Tsao from H.C. Wainwright initiated coverage with a Buy rating on Rezolute (RZLT – Research Report) and a price target of $21.00. The company’s shares closed last Monday at $6.45, close to its 52-week

Radius Health (RDUS) Receives a Hold from H.C. Wainwright

H.C. Wainwright analyst Douglas Tsao reiterated a Hold rating on Radius Health (RDUS – Research Report) today and set a price target of $25.00. The company’s shares closed last Friday at $20.60. According to TipRanks.com, Tsao is a 5-star analyst